share_log

Needham Maintains Buy on NuVasive, Lowers Price Target to $53

Benzinga Real-time News ·  Sep 30, 2022 05:28

Needham analyst David Saxon maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $67 to $53.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment